Quarterly report pursuant to Section 13 or 15(d)

Statements of Cash Flows (unaudited)

v3.24.3
Statements of Cash Flows (unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (9,136,523) $ (5,660,717)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 627,834 393,614
Increase (decrease) in cash resulting from changes in:    
Prepaid expenses and other current assets (3,095) 11,294
Accounts payable (10,324) (22,244)
Accrued and other current liabilities 272,774 16,427
Total adjustments to reconcile net loss to net cash used in operations 887,189 399,091
Net cash used in operating activities (8,249,334) (5,261,626)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock, pre-funded warrants, and warrants, net of issuance costs 6,955,611 5,651,668
Proceeds from exercise of pre-funded warrants 168 187
Payment for fractional shares in reverse stock split (828) (40)
Net cash provided by financing activities 6,954,951 5,651,815
Net increase (decrease) in Cash and cash equivalents (1,294,383) 390,189
Cash and cash equivalents at beginning of period 7,438,135 6,241,294
Cash and cash equivalents at end of period 6,143,752 6,631,483
Non-cash financing activities:    
Issuance of abeyance shares (45) 0
Incremental fair value of May 2024 warrant inducement 1,526,232 0
Issuance costs in accounts payable or accrued expenses 60,051 0
Incremental fair value of March 2023 warrant modification   144,765
Supplemental disclosure:    
Cash paid for taxes $ 950 $ 950